ASP Isotopes Inc. Provides Corporate Update

Core Viewpoint - ASP Isotopes Inc. is advancing its operations in isotope production, particularly focusing on highly enriched Carbon-14 and Ytterbium-176, with expectations of generating revenue in the near term and expanding its production capabilities through new facilities [1][2][3]. Group 1: Carbon-14 Production - The company and its North American partner, RC14, began processing feedstock for highly enriched Carbon-14 in December 2023, with first revenues expected in the first half of 2024 [1][2]. - A multi-year take-or-pay contract with RC14 guarantees a minimum revenue of $2.5 million per annum, with the first batch processing expected to take approximately six months [2]. Group 2: Ytterbium-176 Facility - Construction of the third isotope enrichment facility in South Africa has commenced, aimed at producing kilogram quantities of highly enriched Ytterbium-176, which is crucial for the production of Lutetium-177 used in oncology [3]. - The facility is expected to start commercial production in 2025, addressing supply chain challenges in the market for Lutetium-177 [3]. Group 3: Quantum Enrichment Technology - The new Ytterbium-176 facility will utilize Quantum Enrichment, an advanced technique under development that employs lasers for isotope production [4]. - The company has entered into MOUs with two US-based Small Modular Reactor companies to utilize Quantum Enrichment for producing HALEU [4]. Group 4: Market Demand and Applications - There is a growing demand for various isotopes, including Silicon-28 for quantum computing and Ytterbium-176 for healthcare applications, indicating a robust market potential for the company's products [6].